Federal Register / Vol. 87, No. 54 / Monday, March 21, 2022 / Notices 15911 

country’s growing infrastructure needs. 

The ACS is the only available survey 

that can provide these levels of data in 

a timely, consistent, and standardized 

manner. 

To evaluate the proposed changes, the 

2022 Content Test will include a control 

and two experimental treatments. The 

Control Treatment will include the 

current ACS (production) version of the 

questions. New topics will also be 

included in this treatment. The Test 

Treatment will include the test question 

version for all topics except household 

roster. Because changes to withinhousehold coverage can impact results 

of person-level questions, the household 

roster question(s) will be the current 

production version in order to avoid 

confounding. Changes to the roster 

question(s) will be tested in a separate 

treatment, called the Roster Treatment. 

Additionally, health insurance coverage, 

labor force, and income will include a 

second set of experimental questions to 

be tested in the Roster Treatment. 

Each topic will be evaluated using a 

variety of metrics, including item 

missing data rates, response 

distributions, comparisons to 

benchmarks and administrative data, 

response reliability, and other topicspecific metrics. Comparisons will be 

made between the Control Treatment 

and the experimental treatments. In 

some cases, the two experimental 

treatments will also be compared. 

Results of the test will inform decisions 

about changing content on the ACS. 

Affected Public: Individuals or 

households. 

Frequency: One-time test. 

Respondent’s Obligation: Mandatory. 

Legal Authority: Title 13 U.S.C. 

Sections 141, 193, and 221. 

This information collection request 

may be viewed at www.reginfo.gov. 

Follow the instructions to view the 

Department of Commerce collections 

currently under review by OMB. 

Written comments and 

recommendations for the proposed 

information collection should be 

submitted within 30 days of the 

publication of this notice on the 

following website www.reginfo.gov/ 

public/do/PRAMain. Find this 

particular information collection by 

selecting ‘‘Currently under 30-day 

Review—Open for Public Comments’’ or 

by using the search function and 

entering either the title of the collection 

or the OMB Control Number 0607–0936. 

Sheleen Dumas, 

Department PRA Clearance Officer, Office of 

the Chief Information Officer, Commerce 

Department. 

[FR Doc. 2022–05937 Filed 3–18–22; 8:45 am] 

BILLING CODE 3510–07–P 

DEPARTMENT OF COMMERCE 

Foreign-Trade Zones Board 

[B–8–2022] 

Foreign-Trade Zone (FTZ) 43—Battle 

Creek, Michigan; Notification of 

Proposed Production Activity; Pfizer, 

Inc. (Lipid Active Pharmaceutical 

Ingredients), Kalamazoo, Michigan 

Pfizer, Inc. (Pfizer) submitted a 

notification of proposed production 

activity to the FTZ Board (the Board) for 

its facility in Kalamazoo, Michigan 

within Subzone 43E. The notification 

conforming to the requirements of the 

Board’s regulations (15 CFR 400.22) was 

received on March 11, 2022. 

Pursuant to 15 CFR 400.14(b), FTZ 

production activity would be limited to 

the specific foreign-status materials/ 

components and specific finished 

products described in the submitted 

notification (summarized below) and 

subsequently authorized by the Board. 

The benefits that may stem from 

conducting production activity under 

FTZ procedures are explained in the 

background section of the Board’s 

website—accessible via www.trade.gov/ 

ftz. The proposed finished products and 

materials/components would be added 

to the production authority that the 

Board previously approved for the 

operation, as reflected on the Board’s 

website. 

The proposed finished products 

include active pharmaceutical 

ingredients for Pfizer’s COVID–19 

vaccine—Lipid ALC-0159 K Finished 

and Lipid ALC-0315 Crude (duty rate is 

3.7% or 6.5%). 

The proposed foreign-status materials 

and components include: Methoxy 

Polyethylene Glycol (MPEG) Acid; 

Enzyme CDX-616; Registered Starter 

Chemical PF-07321332; 2,2,6,6- 

Tetramethylpiperidine-1-Oxyl; 1- 

Propanephosphonic Acid Cyclic 

Andydrid; 4-Amino-1-Butanol; 

Tetamine NS Succinate Salt; and, 2- 

Hexyldecanoic Acid (duty rate ranges 

from duty free to 6.5%). The request 

indicates that certain materials/ 

components are subject to duties under 

Section 301 of the Trade Act of 1974 

(Section 301), depending on the country 

of origin. The applicable Section 301 

decisions require subject merchandise 

to be admitted to FTZs in privileged 

foreign status (19 CFR 146.41). 

Public comment is invited from 

interested parties. Submissions shall be 

addressed to the Board’s Executive 

Secretary and sent to: ftz@trade.gov. The 

closing period for their receipt is May 2, 

2022. 

A copy of the notification will be 

available for public inspection in the 

‘‘Online FTZ Information System’’ 

section of the Board’s website. 

For further information, contact Diane 

Finver at Diane.Finver@trade.gov. 

Dated: March 15, 2022. 

Andrew McGilvray, 

Executive Secretary. 

[FR Doc. 2022–05810 Filed 3–18–22; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

Bureau of Industry and Security 

Emerging Technology Technical 

Advisory Committee; Notice of 

Partially Closed Meeting 

The Emerging Technology Technical 

Advisory Committee (ETTAC) will meet 

on April 8, 2022, at 11 a.m., Eastern 

Daylight Time. The meeting will be 

available via teleconference. The 

Committee advises the Office of the 

Assistant Secretary for Export 

Administration on the identification of 

emerging and foundational technologies 

with potential dual-use applications as 

early as possible in their developmental 

stages both within the United States and 

abroad. 

Agenda 

Open Session 

1. Welcome and Introductions. 

2. Introduction by the Bureau of 

Industry and Security Leadership. 

3. Presentation: Bringing the 

Chipmakers Home—Attracting 

Manufactures and the Talent to Sustain 

Them. Questions and Answers. 

4. Public Comments/Announcements. 

Closed Session 

5. Discussion of matters determined to 

be exempt from the provisions relating 

to public meetings found in 5 U.S.C. 

App. 10(a)(1) and 10(a)(3). 

The open session will be accessible 

via teleconference. To join the 

conference, submit inquiries to Ms. 

Yvette Springer at Yvette.Springer@

bis.doc.gov no later than April 1, 2022. 

To the extent time permits, members 

of the public may present oral 

statements to the Committee. The public 


khammond on DSKJM1Z7X2PROD with NOTICES